🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#Editorial This IJGC #2025SpecialIssue is dedicated to Michael Maxwell Frumovitz, MD, whom we lost in July 2024 because of pancreatic cancer much too early... He was passionate about studying rare #gynecologicalcancers and was an international thought leader 🤍 🤍 ▶️

On this #InternationalWomensDay our entire DMT along with IGCS affirms our shared goal to #AccelerateAction through mentorship, education, idea-sharing and advocacy to create a world where all women have access to excellent care. MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center Nadeem R. Abu-Rustum

4 year comprehensive Training Program for individuals who completed their Residency in OB/GYN. 2 years protected research in world class laboratories followed by complex surgical training including robotics, mis and complex open surgeries. karriere.klinikum.uni-heidelberg.de/index.php?ac=j…

Fantastic presentation on opportunistic salpingectomy for #ovarian cancer risk reduction by Team Ovary’s own Kara Long. Exciting work on this very important topic! MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center

🔥The dynamic duo Drs. Rebecca Stone and Kara Long leading our 🇺🇸 efforts in opportunistic #salpingectomy to reduce #ovariancancer. Hear their SGO post-session updates! #SGOMtg #SGO2025 Karen Lu

Our amazing fellow #clarissalam looked at role of pre-operative imaging in #endometrialcancer and found that symptoms/physical exam were critical in low grade EC but that imaging found disease in asymptomatic patients with high grade EC MSKCC Team Uterus

Proud to share our article and thankful for the mentorship of Mario M. Leitao, Jr and Nadeem R. Abu-Rustum. It’s time to revisit margin status in vulvar cancer!

Incredible talk this morning by Susana Banerjee!

Amazing talk and then dinner with the amazing and brilliant Dr. Banerjee from the Royal Marsden! ⁦Team Ovary, Memorial Sloan Kettering Cancer Center⁩ ⁦MSKCC Team Uterus⁩

April 2025 IJGC Journal Club: Effect of substantial LVSI on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma youtu.be/_ZyMkKWigJ0?si… via YouTube

🚨Is Fertility Preservation an Option in Unconventional Situations? with Prof Nadeem R. Abu-Rustum💐 🎥 m.youtube.com/watch?v=qDSgG0… 👋 Stay tuned for the fulltext publication IJGC Prof. Dr. İlker Kahramanoğlu European Network of Young Gynae Oncologists ESGO OncoAlert GYN Cancer | #GYNCSM @GynMe4@OncoAlert Team Ovary, Memorial Sloan Kettering Cancer Center

Take a look at this innovative manuscript from Aaron Praiss MD Dmitriy Zamarin MD PhD Lea A. Moukarzel Tiffany Sia MD Ryan Kahn, MD, MHS and team evaluating tumor stress response during cytoreductive surgery for #ovarian cancer. Team Ovary, Memorial Sloan Kettering Cancer Center MSKCC Team Uterus pubmed.ncbi.nlm.nih.gov/40256326/

So great seeing Kenneth H Kim speak at NYU Langone Health’s conference “Harnessing the Power of Artificial Intelligence in Obstetric & Gynecologic Care”. The needle is moving quickly!!

Artificial intelligence in the diagnosis & management of gynecologic cancer pubmed.ncbi.nlm.nih.gov/40277295/ AI presents significant potential to improve outcomes in Gyn oncology, particularly in bridging healthcare gaps in resource-limited settings.Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center

Our recent paper sciencedirect.com/science/articl… evaluating AR headsets for 3D volumetric rendering demonstrated high accuracy in predicting the extent of ovarian cancer spread prior to cytoreductive surgery. Ryan Kahn, MD, MHS MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center

Today on World Ovarian Cancer Day please consider donating to Fred's Team “Team Ovary” to fund ovarian cancer research at MSKCC. We can continue to do better for our patients! Memorial Sloan Kettering Cancer Center Team Ovary, Memorial Sloan Kettering Cancer Center #worldovariancancerday #GoFredsTeam mskcc.convio.net/goto/MoeB

🚨The FDA granted accelerated approval to avutometinib & defactinib for adults with KRAS-mutated recurrent low-grade serous #ovariancancer. Congrats to MSK's Rachel Grisham, Global Lead Principal Investigator of GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301! bit.ly/3ETZS2F

What a way to end clinic! United Healthcare just denied prophylactic surgery for a patient with BRCa1 mutation!! This ridiculousness needs to end and shame on United Healthcare!

So proud of Sara Moufarrij who is teaching us all about uterine LMS under the guidance of the one and only #marteehensley! MSKCC Team Uterus Team Ovary, Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center MSK Department of Medicine

The PFS benefit was secondary endpoint. This will not change what we do here. Patients fit for surgery where primary CGr is possible with stage III disease will undergo pDS. So it’s never an all or none!! Not all patients should have NACT either